GALECTIN THERAPEUTICS INC ($GALT)
Filing Information
| Accession Number | 0001133416-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
24,375
Total Value
$43,082.81
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Dec 31, 2025 | Exercise/Conversion | 8,125 | $1.23 | $9,993.75 | 8,125 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Dec 31, 2025 | Sale | 8,125 | $4.07 | $33,089.06 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock option (right to buy) | Derivative | Dec 31, 2025 | Exercise/Conversion | 8,125 | $0.00 | $0.00 | 40,625 | Direct | โ | View Details |